2023
DOI: 10.1016/j.phymed.2023.154953
|View full text |Cite
|
Sign up to set email alerts
|

Orcinol glucoside targeted p38 as an agonist to promote osteogenesis and protect glucocorticoid-induced osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 34 publications
0
2
0
Order By: Relevance
“…These results indicated that DEN alleviated the inhibitory effect of dexamethasone on the P-Jun and P-p38 expression after cotreatment for 3, 7, and 14 days ( P < 0.05, P < 0.01, Figure G). Considering that JNK and p38 pathway could block the effect of GC by inhibiting the nuclear translocation of GR, , the effect of DEN on the nucleation of GR by immunofluorescence was investigated. Dexamethasone increased the transfer of GR into the nucleus, but after 3 days of treatment with DEN, GR nuclear translocation was significantly reduced ( P < 0.01, Figure H).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…These results indicated that DEN alleviated the inhibitory effect of dexamethasone on the P-Jun and P-p38 expression after cotreatment for 3, 7, and 14 days ( P < 0.05, P < 0.01, Figure G). Considering that JNK and p38 pathway could block the effect of GC by inhibiting the nuclear translocation of GR, , the effect of DEN on the nucleation of GR by immunofluorescence was investigated. Dexamethasone increased the transfer of GR into the nucleus, but after 3 days of treatment with DEN, GR nuclear translocation was significantly reduced ( P < 0.01, Figure H).…”
Section: Resultsmentioning
confidence: 99%
“…JNK and p38 inhibitors eliminated the osteogenic protective effect of DEN on dexamethasone-treated BMSCs. Activation of JNK and p38 lead to decreased GR function through phosphorylation. , Here, we addressed that dexamethasone enhanced the nuclear translocation of GR; however, inhibition of JNK or p38 did not significantly affect this change induced by dexamethasone treatment. In conclusion, DEN ameliorates GC-induced bone loss and cell osteoblastic inhibition by promoting JNK and p38 MAPK pathways and restraining GR nuclear translocation.…”
Section: Discussionmentioning
confidence: 96%